|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||
| Cash and cash equivalents | ||||||||
| Prepayments and other receivables | ||||||||
| Taxation receivable | ||||||||
| Related party receivables | ||||||||
| Total current assets | ||||||||
| Non – Current Assets: | ||||||||
| Property and equipment, net | ||||||||
| Right of use asset | ||||||||
| Investment in related party | ||||||||
| Total non-current assets | ||||||||
| Total assets | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Deferred Income | ||||||||
| Lease Liability | ||||||||
| Other liabilities | ||||||||
| Total current liabilities | ||||||||
| Lease Liability (Non-Current) | ||||||||
| Total liabilities | ||||||||
| Shareholders’ Equity: | ||||||||
| Called up share capital (120,507,401 shares are issued and outstanding; 2024:111,462,617) | ||||||||
| Share premium | ||||||||
| Share based payment reserve – Options | ||||||||
| Share based payment reserve – warrants | ||||||||
| Merger relief reserve | ||||||||
| Treasury shares | ||||||||
| RSU reserve | ||||||||
| Shares to be issued reserve | ||||||||
| Translation reserve | ||||||||
| Retained earnings | ||||||||
| Total shareholders’ equity | ||||||||
| Total liabilities and shareholders’ equity | ||||||||
Loading...
